Navigation Links
EMBO Gold Medal 2012 awarded to Jiri Friml

Friml receives the award for defining how the plant hormone auxin functions to regulate plant development. He was also recognized for showing how the auxin-governed molecular processes optimise adaptation of plant development and growth to ever-changing environmental conditions. The 39-year-old scientist has published more than 130 original research publications and reviews in top international journals and belongs to the most cited plant biologists worldwide.

"His groundbreaking results influence and continue to shape present and future efforts in a number of areas of plant biology research," stated EMBO Member Ferenc Nagy. The results of Friml's research are of major importance to agriculture as they provide a basis for targeted engineering that could lead to the development of plants that produce higher yields or which are more resistant to drought.

"Being awarded by my peers from EMBO is an immense honour and gives me great encouragement for my further work. I would like to think that this award is not only for me but also in a wider sense for plant research which deserves more support and could definitely benefit from more awareness," said the Gold Medal winner.

Jiř Friml's research highlights include:

  • Showing that transport-dependent morphogenetic auxin gradients and maxima underlie processes such as embryonal development, formation of all plant organs, differentiation and regeneration of tissues as well as responses to external signals such as light and gravity
  • Establishing the concept that auxin acts as a versatile trigger providing spatial and temporal information to reprogram cellular behavior
  • Demonstrating the clathrin-mediated mechanism of endocytosis in plants along with the developmental significance of this process in the field of plant cell biology
  • Revealing mechanisms that govern cell polarity in plants and its importance for both hormonal signaling and development

Career stages

Jiř Friml performed his PhD work at the Max Planck Institute for Plant Breeding Research in Cologne, Germany, and obtained his PhD in Biology from the University of Cologne in 2000. He was also awarded a PhD in Biochemistry in 2002 from Masaryk University in Brno, Czech Republic. In his doctoral studies, he was already providing crucial insight into the mechanisms of transport and distribution of auxin and its role in plant development. For his outstanding scientific contributions during his PhD studies, the Max Planck Society awarded him the prestigious Otto-Hahn Medal.

After finishing his doctoral studies, he received a grant from the Volkswagen Foundation to start his independent research group. At the age of 33, Friml became a professor and head of the Institute of Plant Cell Biology in Gttingen, Germany. Currently, he is a professor in the Department of Plant Systems Biology at the University of Ghent and head of a research group at the Flanders Institute of Biotechnology in Ghent. He also holds an appointment with the Central European Institute of Technology, University Brno, Czech Republic. Friml will move to The Institute of Science and Technology, Austria, at the end of 2012.

The achievements of the Czech-born scientist have been internationally recognised: he was elected a member of EMBO, he is a fellow of the American Association for the Advancement of Science and the recipient of the Heinz-Meyer Leibnitz prize and the Krber European Science Award.

Jiř Friml will receive the EMBO Gold Medal and an award of 10,000 euros on 23 September 2012 at The EMBO Meeting in Nice where he will give a lecture about his research.


Contact: Barry Whyte
European Molecular Biology Organization

Related medicine news :

1. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
2. $9 million grant awarded to UH to study, treat learning disabilities
3. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
4. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
5. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
6. Southeast program to fight diabetes awarded nearly $10 million by HHS
7. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
8. 29 Johns Hopkins stem cell researchers awarded funding
9. Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains
10. FirstVitals Health and Wellness, Inc. awarded $4 Million CMS Innovation Grant for Unique Telehealth Diabetes Progam Focused on Glycemic Control and Prevention of Diabetic Foot Complications
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: